Sentences with phrase «stockholders following the filing»

Mills and Brookfield expect to file a proxy statement in connection with the special meeting of stockholders following the filing of Mills» annual report for the year ended Dec. 31, 2006.

Not exact matches

In addition to factors previously disclosed in Tesla's and SolarCity's reports filed with the U.S. Securities and Exchange Commission (the «SEC») and those identified elsewhere in this document, the following factors, among others, could cause actual results to differ materially from forward - looking statements and historical performance: the ability to obtain regulatory approvals and meet other closing conditions to the transaction, including requisite approval by Tesla and SolarCity stockholders, on a timely basis or at all; delay in closing the transaction; the ultimate outcome and results of integrating the operations of Tesla and SolarCity and the ultimate ability to realize synergies and other benefits; business disruption following the transaction; the availability and access, in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provisions.

In addition, the Board would like to remind MathStar stockholders of the following information disclosed in the Offer to Purchase, filed as Exhibit (a)(1)(A) of the Tiberius Schedule TO:

We've been following ASPN (see our ASPN post archive) because it's trading at a discount to its $ 1.17 per share liquidation value and there are several potential catalysts in the stock, including a 13D filing from Tymothi O. Tombar, a plan to distribute substantially all of the net, after - tax proceeds from the completion of the Venoco sale to its stockholders ($ 5.3 M), and the possibility that the company will dissolve.

Following stockholder approval of the Plan of Dissolution and the filing of articles of dissolution, the Company would delist its common stock from NASDAQ.

ROCKVILLE, MD. — February 23, 2009 — Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)(«Vanda» or the «Company») today issued the following statement regarding two letters sent to Vanda by Tang Capital Partners, LP («TCP») and a SEC filing by TCP stating its intent to, among other things, nominate two directors to stand for election at Vanda's 2009 Annual Meeting of Stockholders and submit proposals at the 2009 Annual Meeting to amend Vanda's bylaws and request that the Board of Directors of Vanda take action to liquidate the Company.